UR
Usha Rani Kurre
About Usha Rani Kurre
Data last updated:
Usha Rani Kurre is an Individual Subscriber at American Institute For Cellular Oncology Private Limited (since 2026).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 American Institute For Cellular Oncology Private Limited U46497TS2026PTC219384 | Individual Subscriber | 14 Jul 2026 | 2026 | Active |
Board colleagues of Usha Rani Kurre
| Name | DIN | Company | Designation |
|---|---|---|---|
| Meena Tummuru | 08158271 | American Institute For Cellular Oncology Private Limited | Individual Subscriber |
| Murali Krishna Reddy Tummuru | 02469013 | American Institute For Cellular Oncology Private Limited | Director |
| Puneeth Babu Anne | 09351752 | American Institute For Cellular Oncology Private Limited | Individual Subscriber |
| Rajesh Bollam | 11010790 | American Institute For Cellular Oncology Private Limited | Individual Subscriber |
| Rajesh Reddy Tummuru | 05346342 | American Institute For Cellular Oncology Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Usha Rani Kurre
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Usha Rani Kurre
Usha Rani Kurre currently holds 1 directorship: American Institute For Cellular Oncology Private Limited (Individual Subscriber, since 14 Jul 2026).
Usha Rani Kurre was first appointed on 14 Jul 2026 as Individual Subscriber at American Institute For Cellular Oncology Private Limited.
The current boards of Usha Rani Kurre's companies include Meena Tummuru (American Institute For Cellular Oncology Private Limited), Murali Krishna Reddy Tummuru (American Institute For Cellular Oncology Private Limited), Puneeth Babu Anne (American Institute For Cellular Oncology Private Limited), Rajesh Bollam (American Institute For Cellular Oncology Private Limited), Rajesh Reddy Tummuru (American Institute For Cellular Oncology Private Limited).